News Stories

HRS 2024: Small diameter defibrillation lead meets safety and effectiveness endpoints in LEADR trial

Medtronic has announced that its investigational OmniaSecure defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals in the global LEADR pivotal trial.

Removing Conduction System Pacing Leads: Good Success So Far

Study reassures, but long dwell times are largely yet to come

Medtronic adds new AI models to its insertable cardiac monitors

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

EHRA 2024: Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ischemic cardiomyopathy patients at high risk for ventricular arrhythmias, results from the randomized PREVENTIVE VT trial show.

EHRA 2024: Closed loop stimulation rate-adaptive pacing may delay sub-clinical AF in sinus node disease

Clinical findings of the B3 study, assessing the impact of closed loop stimulation on the incidence of sub-clinical atrial fibrillation (AF) in sinus node disease patients, have been presented during a late-breaking trial session at the European Heart Rhythm Association (EHRA) 2024 congress (7–9 April, Berlin, Germany).